3 completed, 2 recruiting, 2 withdrawn. 3 Phase 1, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Brain and Nervous System: new trials by email Literature Review of Brain and Nervous System trials Research Report on Brain and Nervous System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms Auricular acupressure in concha area, Auricular acupressure in earlobe - Functional Dyspepsia, Insomnia | Not applicable | Recruiting | The First Affiliated Hospital of Zhejiang Chinese Medical University | 176 | 2025-10-30 | 2026-03-02 |
| B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme B7-H3CART - Brain and Nervous System | Phase 1 | Recruiting | Stanford University | 39 | 2022-07-12 | 2026-09-15 |
| Patients Who Receive 131 I-MIBG Brain and Nervous System | Withdrawn | Wake Forest University Health Sciences | 2021-03-10 | 2022-12-14 | ||
| Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma Nivolumab - Brain and Nervous System, Eye and Orbit | Phase 1 | Completed | Wake Forest University Health Sciences | 14 | 2020-03-31 | 2025-12-30 |
| Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors Computed Tomography, Medical Device, Cone-Beam Computed Tomography - Brain and Nervous System, Intracranial Neoplasm | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 12 | 2017-02-24 | 2025-10-15 |
| Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases Brain and Nervous System | Withdrawn | Stanford University | 2014-10-01 | 2022-02-04 | ||
| A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors Irinotecan, Thalidomide - Brain and Nervous System, Cancer | Phase 1 | Completed | University of New Mexico | 10 | 2000-03-01 | 2010-01-07 |
Neurologic Manifestations (7) · Brain Neoplasms (2) · Central Nervous System Neoplasms (1) · Head and Neck Neoplasms (1) · Lymphoma (1) · Neoplasms (1) · Sleep Initiation and Maintenance Disorders (1)
Nervous System Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Brain Diseases (2) · Central Nervous System Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Nervous System Neoplasms (2) · Central Nervous System Neoplasms (1) · Dyssomnias (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Equipment and Supplies (1) · Irinotecan (1) · Nivolumab (1) · Thalidomide (1)
Stanford University (2) · Wake Forest University Health Sciences (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · The First Affiliated Hospital of Zhejiang Chinese Medical University (1) · University of New Mexico (1)
United States (5) · China (1)
Dennie Jones, MD (1) · Javier Oesterheld, MD (1) · JianNong Wu (1) · Reena Thomas, MD, PhD (1) · Steven Chang (1) · Steven Park, MD (1) · Voichita Bar Ad, MD (1)